Innongem 200mg Injection
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Gemcitabine (200mg)
Overview Innongem 200mg Injection
Geminin 200mg Injection treats several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe complications. Therapeutic effects may not be apparent immediately; continued use is necessary unless otherwise directed. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can lower blood cell counts, increasing infection risk. Regular blood tests monitoring blood cell levels, as well as heart, liver, and uric acid levels are essential. Prior to treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, and all medications you are taking, including antibiotics. Drug interactions are possible. Pregnancy and breastfeeding are contraindicated. Both partners should employ effective contraception throughout treatment.
Uses of Innongem 200mg Injection
Lung cancer (non-small cell type), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Innongem 200mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Innongem 200mg Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Innongem 200mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Innongem 200mg Injection works:
Innongem 200mg Injection disrupts cancer cell proliferation by replacing essential DNA and RNA components, thereby halting their growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Innongem 200mg Injection and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Innongem 200mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Innongem 200mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The administration of Innongem 200mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Innongem 200mg Injection to individuals with renal impairment. Physician consultation is recommended. Pre-treatment assessment of kidney function is advisable, along with ongoing monitoring post-treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Innongem 200mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Innongem 200mg Injection :
NA
Facts to Know About Innongem 200mg Injection
| Label | Value |
|---|---|
| Type of Compound | Pyrimidine Base Analog |
| Addictive | None. |
| Type of Treatment | Cancer treatments |
| Mechanism of Action | Metabolic antagonists |
3,018 People bought this recently